BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 20972533)

  • 21. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
    Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice.
    Ma T; Lu W; Wang Y; Qian P; Tian H; Gao X; Yao W
    Eur J Pharmacol; 2022 Jan; 914():174635. PubMed ID: 34800466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
    Flock G; Baggio LL; Longuet C; Drucker DJ
    Diabetes; 2007 Dec; 56(12):3006-13. PubMed ID: 17717280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy - A review.
    Conlon JM; O'Harte FPM; Flatt PR
    Peptides; 2022 Jan; 147():170706. PubMed ID: 34861327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterisation of a novel glucagon like peptide-1 receptor antibody.
    Biggs EK; Liang L; Naylor J; Madalli S; Collier R; Coghlan MP; Baker DJ; Hornigold DC; Ravn P; Reimann F; Gribble FM
    Diabetologia; 2018 Mar; 61(3):711-721. PubMed ID: 29119245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
    Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
    Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
    Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
    Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.
    Ayala JE; Bracy DP; James FD; Julien BM; Wasserman DH; Drucker DJ
    Endocrinology; 2009 Mar; 150(3):1155-64. PubMed ID: 19008308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.
    Ryskjaer J; Deacon CF; Carr RD; Krarup T; Madsbad S; Holst J; Vilsbøll T
    Eur J Endocrinol; 2006 Sep; 155(3):485-93. PubMed ID: 16914604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
    Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK
    Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 beta cell.
    Pan QR; Li WH; Wang H; Sun Q; Xiao XH; Brock B; Schmitz O
    Horm Metab Res; 2009 Nov; 41(11):799-804. PubMed ID: 19672815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells.
    Manchanda Y; Bitsi S; Chen S; Broichhagen J; Bernardino de la Serna J; Jones B; Tomas A
    Endocrinology; 2023 Mar; 164(5):. PubMed ID: 36774542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Mol Cell Endocrinol; 2016 Aug; 431():133-44. PubMed ID: 27179756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for Involvement of GIP and GLP-1 Receptors and the Gut-Gonadal Axis in Regulating Female Reproductive Function in Mice.
    Khan D; Ojo OO; Woodward OR; Lewis JE; Sridhar A; Gribble FM; Reimann F; Flatt PR; Moffett RC
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.